Related Experiment Video
Updated: Apr 21, 2026

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
Published on: March 17, 2019
Is impulsivity a symptom of initial tobacco withdrawal? A meta-analysis and qualitative systematic review
John R Hughes1, Miriam Dash2, Peter W Callas2
1Department of Psychiatry, Psychology and Family Practice, University of Vermont, Burlington, VT; john.hughes@med.uvm.edu.
Introduction:
We reviewed existing experimental studies of whether impulsivity is a symptom of tobacco withdrawal.
Methods:
We conducted searches of PubMed, PsychInfo and other sources to find experimental studies that measured self-reported impatience, delay discounting (DD), or response inhibition (RI) while smoking and during initial abstinence in untreated smokers. Two of the authors (JRH and MD) independently examined titles, then abstracts, and then articles to locate studies and to enter study characteristics. Major inclusion criteria were (a) adult daily smokers, (b) measured impulsivity before and after ≥13hr of abstinence, and (c) no pharmacological treatment provided.
Results:
We located 6 studies that examined self-reported impatience, 4 that examined DD, and 3 that examined RI. A meta-analysis was feasible only for the impatience studies. A random-effects meta-analysis found initial abstinence increased impatience by 0.44 points on 4-point scales (p = .0001). Importantly, 3 of the 4 impatience studies that examined the time course found a time-limited pattern consistent with a withdrawal effect. Qualitative review of the DD and RI studies found mixed results such that no conclusions could be made.
Conclusion:
The number of studies on impulsivity and tobacco abstinence is surprisingly small. Self-reported impatience appears to be a tobacco withdrawal symptom but whether it is associated with functional changes in DD or RI is unclear. Further studies of whether abstinence produces objective changes in impulsivity, and whether increases in impulsivity during abstinence prompt relapse, are needed.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...

